{"id":"placebo-skin-patch-and-placebo-tablets","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos work via psychological and neurobiological mechanisms including expectation, conditioning, and activation of endogenous pain-relief and reward pathways. The placebo effect is a well-documented phenomenon in clinical research where inert treatments produce measurable improvements in symptoms, particularly for subjective conditions. Placebos are used as control comparators in randomized controlled trials to establish the efficacy of active drugs beyond the placebo response.","oneSentence":"A placebo produces therapeutic effects through patient expectation and the psychobiological placebo response, with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:13.674Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in clinical trials (non-therapeutic use)"}]},"trialDetails":[{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT02271919","phase":"PHASE4","title":"Varenicline and Combined NRT for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-05-14","conditions":"Cigarette Smoker, Tobacco Use Disorder","enrollment":631},{"nctId":"NCT05388656","phase":"PHASE4","title":"Estrogen Variability and Irritability During the Menopause Transition","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-06-15","conditions":"Menopause, Irritable Mood","enrollment":40},{"nctId":"NCT07226141","phase":"PHASE1, PHASE2","title":"Valproate for the Treatment of Residual Amblyopia","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-01-01","conditions":"Amblyopia, Amblyopia Unilateral, Amblyopia, Anisometropic","enrollment":28},{"nctId":"NCT06990854","phase":"NA","title":"Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial Protocol","status":"NOT_YET_RECRUITING","sponsor":"Dexiong Han","startDate":"2025-07-01","conditions":"Postherpetic Neuralgia ( PHN )","enrollment":207},{"nctId":"NCT07040280","phase":"PHASE2","title":"Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma","status":"NOT_YET_RECRUITING","sponsor":"Eastern Cooperative Oncology Group","startDate":"2025-10-31","conditions":"Melanoma","enrollment":120},{"nctId":"NCT06798571","phase":"PHASE4","title":"Role of Menopause in Thermoregulation","status":"RECRUITING","sponsor":"Penn State University","startDate":"2025-03-01","conditions":"Menopause, Aging","enrollment":24},{"nctId":"NCT06372210","phase":"NA","title":"A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2023-06-26","conditions":"Mental Disorder, Schizophrenia, Major Depressive Disorder","enrollment":54},{"nctId":"NCT05387707","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis","status":"TERMINATED","sponsor":"Cara Therapeutics, Inc.","startDate":"2022-08-16","conditions":"Pruritus, Atopic Dermatitis","enrollment":287},{"nctId":"NCT05789186","phase":"EARLY_PHASE1","title":"Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents","status":"UNKNOWN","sponsor":"Chen Qian","startDate":"2023-05-01","conditions":"Depression","enrollment":108},{"nctId":"NCT05301660","phase":"EARLY_PHASE1","title":"Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia","status":"UNKNOWN","sponsor":"Sir Run Run Shaw Hospital","startDate":"2022-03-22","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT02122198","phase":"NA","title":"Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-09-08","conditions":"Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction","enrollment":17},{"nctId":"NCT02091882","phase":"PHASE4","title":"Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2014-03-21","conditions":"Device Latency","enrollment":30},{"nctId":"NCT02859142","phase":"PHASE4","title":"Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-03-29","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":122},{"nctId":"NCT04035603","phase":"PHASE2","title":"Multimodal Cue Exposure Therapy for Smoking Cessation","status":"WITHDRAWN","sponsor":"Boston University Charles River Campus","startDate":"2020-10-01","conditions":"Smoking Cessation","enrollment":""},{"nctId":"NCT04329923","phase":"PHASE2","title":"The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)","status":"TERMINATED","sponsor":"Ravi Amaravadi, MD","startDate":"2020-04-09","conditions":"COVID-19","enrollment":173},{"nctId":"NCT00089843","phase":"PHASE2, PHASE3","title":"Bone Loss in Women With Anorexia Nervosa","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2003-06","conditions":"Anorexia Nervosa","enrollment":77},{"nctId":"NCT01212770","phase":"PHASE3","title":"PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-09-30","conditions":"Psoriatic Arthritis","enrollment":505},{"nctId":"NCT02256540","phase":"NA","title":"The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-08","conditions":"Endothelial Dysfunction","enrollment":25},{"nctId":"NCT03967327","phase":"PHASE3","title":"A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain","status":"UNKNOWN","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","startDate":"2019-04-22","conditions":"Cancer Pain","enrollment":194},{"nctId":"NCT01999114","phase":"PHASE1","title":"The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2012-03","conditions":"ECG Effects","enrollment":328},{"nctId":"NCT00066157","phase":"PHASE2, PHASE3","title":"Alzheimer's Disease: Therapeutic Potential of Estrogen","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2001-09","conditions":"Alzheimer Disease","enrollment":42},{"nctId":"NCT02404532","phase":"PHASE4","title":"Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2015-02","conditions":"Device Latency","enrollment":30},{"nctId":"NCT01139996","phase":"PHASE4","title":"Use of Transdermal Clonidine in Trauma Patients","status":"TERMINATED","sponsor":"Memorial Health University Medical Center","startDate":"2010-05","conditions":"Delirium","enrollment":22},{"nctId":"NCT00000437","phase":"PHASE4","title":"Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)","status":"COMPLETED","sponsor":"The Scripps Research Institute","startDate":"1997-09-26","conditions":"Alcoholism, Smoking","enrollment":60},{"nctId":"NCT02267057","phase":"PHASE4","title":"Efficacy of Pain Treatment on Depression in Patients With Dementia","status":"COMPLETED","sponsor":"University of Bergen","startDate":"2014-08","conditions":"Depression, Pain, Dementia","enrollment":163},{"nctId":"NCT00852540","phase":"PHASE3","title":"Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-04","conditions":"Skin Infections, Bacterial","enrollment":410},{"nctId":"NCT02524561","phase":"NA","title":"KEEPS Mammographic Density And Breast Health Ancillary Study","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2005-09","conditions":"Mammographic Density, Abnormal Mammogram","enrollment":517},{"nctId":"NCT02616068","phase":"PHASE3","title":"Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma","status":"COMPLETED","sponsor":"Daiichi Sankyo Brasil Farmacêutica LTDA","startDate":"2015-10","conditions":"Trauma, Pain","enrollment":242},{"nctId":"NCT00030147","phase":"PHASE4","title":"Raloxifene and Rimostil for Perimenopause-Related Depression","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2002-02","conditions":"Perimenopausal Depression, Depression","enrollment":65},{"nctId":"NCT01082874","phase":"PHASE3","title":"PeriOperative ISchemic Evaluation-2 Trial","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2010-07","conditions":"Cardiovascular Disease","enrollment":10010},{"nctId":"NCT01456936","phase":"PHASE4","title":"Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-11","conditions":"Smoking Cessation","enrollment":8144},{"nctId":"NCT01314001","phase":"PHASE3","title":"Pharmacogenetics of Nicotine Addiction Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-12","conditions":"Nicotine Addiction","enrollment":1246},{"nctId":"NCT00920985","phase":"PHASE3","title":"US Cycle Control and Blood Pressure Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-06","conditions":"Contraception","enrollment":346},{"nctId":"NCT02517957","phase":"PHASE2","title":"Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2015-08","conditions":"Eczema","enrollment":342},{"nctId":"NCT00151970","phase":"PHASE2","title":"Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD","status":"COMPLETED","sponsor":"Noven Therapeutics","startDate":"2005-06","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":128},{"nctId":"NCT00444574","phase":"PHASE3","title":"Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD","status":"COMPLETED","sponsor":"Noven Therapeutics","startDate":"2004-09","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":282},{"nctId":"NCT01387672","phase":"PHASE3","title":"Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2011-09","conditions":"Osteoporosis","enrollment":265},{"nctId":"NCT01628926","phase":"PHASE3","title":"A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Co., Ltd.","startDate":"2009-06","conditions":"Parkinson's Disease","enrollment":420},{"nctId":"NCT00308763","phase":"NA","title":"Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2004-01","conditions":"Tobacco Use Disorder","enrollment":594},{"nctId":"NCT01259115","phase":"PHASE1","title":"Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2002-10","conditions":"Healthy","enrollment":20},{"nctId":"NCT00659737","phase":"NA","title":"Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Drexel University College of Medicine","startDate":"2008-04","conditions":"Nausea, Vomiting","enrollment":115},{"nctId":"NCT01097902","phase":"PHASE1","title":"Study of Experimental Models of Pain and Inflammation.","status":"COMPLETED","sponsor":"Martin Angst","startDate":"2010-02","conditions":"Pain, Inflammation","enrollment":15},{"nctId":"NCT01148537","phase":"PHASE1","title":"The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2004-07","conditions":"Healthy Volunteers","enrollment":132},{"nctId":"NCT00315445","phase":"PHASE3","title":"The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"1997-12","conditions":"Back Pain","enrollment":134},{"nctId":"NCT00552799","phase":"PHASE4","title":"RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2006-07","conditions":"Cellulitis/Erysipelas of the Leg","enrollment":274},{"nctId":"NCT01450839","phase":"PHASE1","title":"E2022 Patch Formulation Multiple Dose Study","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2011-09","conditions":"Healthy","enrollment":16},{"nctId":"NCT00860925","phase":"PHASE4","title":"PeriOperative ISchemic Evaluation-2 Pilot","status":"COMPLETED","sponsor":"McMaster University","startDate":"2009-05","conditions":"Cardiovascular Disease","enrollment":90},{"nctId":"NCT00313105","phase":"PHASE2, PHASE3","title":"Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches","status":"UNKNOWN","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2006-04","conditions":"Tobacco Dependence","enrollment":600},{"nctId":"NCT00622752","phase":"PHASE2","title":"Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes","status":"COMPLETED","sponsor":"Evotec Neurosciences GmbH","startDate":"2008-02","conditions":"Smoking Cessation","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo skin patch and placebo tablets","genericName":"Placebo skin patch and placebo tablets","companyName":"National Institute of Mental Health (NIMH)","companyId":"national-institute-of-mental-health-nimh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo produces therapeutic effects through patient expectation and the psychobiological placebo response, with no active pharmacological mechanism. Used for Control arm in clinical trials (non-therapeutic use).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}